← back to search

Haiquan Lu

Johns Hopkins University · US
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Cancer Research and Treatments, and Epigenetics and DNA Methylation.
h-index
22
citations
3,563
works
115
NIH funding
primary concept
email

Recent publications

Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter study
npj Precision Oncology 2025cited by 7position: middledoi
Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment
Advanced Science 2024cited by 6position: lastdoi
Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness
Journal of Clinical Investigation 2020cited by 162position: firstdoi
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
Proceedings of the National Academy of Sciences 2018cited by 131position: middledoi
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
Cell Reports 2017cited by 167position: firstdoi
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m <sup>6</sup> A-demethylation of NANOG mRNA
Proceedings of the National Academy of Sciences 2016cited by 1,011position: middledoi
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
Oncotarget 2016cited by 267position: middledoi
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
Proceedings of the National Academy of Sciences 2015cited by 429position: middledoi
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
Proceedings of the National Academy of Sciences 2015cited by 267position: firstdoi
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
Oncotarget 2014cited by 116position: middledoi
Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A
Molecular Cancer Therapeutics 2013cited by 81position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Gregg L. Semenza · World Food Programme8 papers (2014–2020)Debangshu Samanta · SK Life Science (United States)6 papers (2014–2018)John W. Bullen · Johns Hopkins Medicine4 papers (2014–2016)Chuanzhao Zhang · Guangdong General Hospital4 papers (2015–2017)Ivan Chen · Johns Hopkins Medicine4 papers (2015–2017)Huimin Zhang · China Agricultural University3 papers (2015–2017)Lisha Xiang · Guizhou University3 papers (2014–2015)Jie Lan · Johns Hopkins Medicine2 papers (2018–2024)Daniele M. Gilkes · Johns Hopkins University2 papers (2014–2015)Hongxia Hu · Johns Hopkins Medicine2 papers (2014–2015)Guangyu Ji · Shandong University1 papers (2024–2024)Youngrok Park · Georgetown University1 papers (2017–2017)Huimin Zhang · Dalian Medical University1 papers (2015–2015)Ru Wang · Academy of Medical Sciences1 papers (2020–2020)You Lü · Tulane University1 papers (2018–2018)Yuanyuan Yang · Nanjing Tech University1 papers (2024–2024)Yuhong Zhang · Dalian Medical University1 papers (2024–2024)Houjie Liang · Creative Commons1 papers (2014–2014)Shengjun Ji · Nanjing Medical University1 papers (2025–2025)Rong Sun · Shandong University1 papers (2024–2024)